Featured
5 ways Biden’s SOTU could advance biotech affordability and innovation
5 ways Biden’s SOTU could advance biotech affordability and innovation

Here are five policies President Biden should include in his State of the Union address on Thursday.

Read More →
Measuring the damage: IRA’s impact on small molecule drug development
Measuring the damage: IRA’s impact on small molecule drug development

Read what one oncology executive discovered when he surveyed the biotech community.

Read More →
PBMs: The Secretive Middlemen for Insurance and Drug Companies
PBMs: The Secretive Middlemen for Insurance and Drug Companies
Read More →